TissueGene, Inc. Company Profile

07:10 EST 21st November 2017 | BioPortfolio

News Articles [9 Associated News Articles listed on BioPortfolio]

Spotlight On TissueGene’s Upcoming Korea IPO

Regenerative drug company TissueGene’s proposed IPO in South Korea is drawing keen interest, coming close on the heels of the...   

Korea approves TissueGene's knee osteoarthritis drug

Korea has approved TissueGene's Invossa-K Inj. as a treatment for patients with osteoarthritis of the knee.  -More- 

TissueGene Recognized During Maryland Commerce, State Departments' Week-Long Trade Mission To South Korea

ROCKVILLE, Md., Sept. 11, 2017 /PRNewswire/ -- A trade and diplomatic mission to South Korea led by officials from the Maryland Department of Commerce and the Maryland Secretary of State's office conc...

TissueGene therapy gets Korean approval for OA

TissueGene, Inc. Awarded $750,000 Maryland Stem Cell Grant For Invossa Clinical Study

  Life Sciences Jobs   ...

TissueGene, Inc. Release: Korea Approves The World's First Cell And Gene Therapy For Knee Osteoarthritis

  Life Sciences Jobs   ...

South Korea OKs First-in-Class Gene Therapy for Osteoarthritis

South Korea’s Ministry of Food and Drug Safety said today that it has approved the country’s first gene therapy for osteoarthritis, the lead product candidate of a Maryland-based regenerative medi...

The IO Switch: Making Tumor-Associated Macrophages Work In Our Favor

Emerging Company Profile: Macrophage Pharma is using novel chemistry to deliver therapies directly into tumor-associated macrophages, switching their activity from...   

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee

The study is being conducted to investigate the safety and activity of TissueGene-C injected into the knee joint of patients with chronic degenerative joint disease (DJD) who will be under...

Companies [2 Associated Companies listed on BioPortfolio]


Starting in 1997, the founders of TissueGene sought to uncover different surgical and gene-based therapeutics for a variety of arthritic conditions. The diligence soon paid off in the form of the firs...

TissueGene, Inc.

More Information about "TissueGene, Inc." on BioPortfolio

We have published hundreds of TissueGene, Inc. news stories on BioPortfolio along with dozens of TissueGene, Inc. Clinical Trials and PubMed Articles about TissueGene, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TissueGene, Inc. Companies in our database. You can also find out about relevant TissueGene, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record